scholarly journals Habitual Choline Intakes across the Childbearing Years: A Review

Nutrients ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 4390
Author(s):  
Emma Derbyshire ◽  
Rima Obeid ◽  
Christiane Schön

Choline is an important nutrient during the first 1000 days post conception due to its roles in brain function. An increasing number of studies have measured choline intakes at the population level. We collated the evidence focusing on habitual choline intakes in the preconceptual, pregnancy, and lactation life stages. We conducted a review including studies published from 2004 to 2021. Twenty-six relevant publications were identified. After excluding studies with a high choline intake (>400 mg/day; two studies) or low choline intake (<200 mg/day; one study), average choline intake in the remaining 23 studies ranged from 233 mg/day to 383 mg/day, even with the inclusion of choline from supplements. Intakes were not higher in studies among pregnant and lactating women compared with studies in nonpregnant women. To conclude, during the childbearing years and across the globe, habitual intakes of choline from foods alone and foods and supplements combined appear to be consistently lower than the estimated adequate intakes for this target group. Urgent measures are needed to (1) improve the quality of choline data in global food composition databases, (2) encourage the reporting of choline intakes in dietary surveys, (3) raise awareness about the role(s) of choline in foetal–maternal health, and (4) consider formally advocating the use of choline supplements in women planning a pregnancy, pregnant, or lactating.

2019 ◽  
Vol 122 (11) ◽  
pp. 1221-1229
Author(s):  
Kevin C. Klatt ◽  
Melissa Q. McDougall ◽  
Olga V. Malysheva ◽  
J. Thomas Brenna ◽  
Mark S. Roberson ◽  
...  

AbstractThe major facilitator superfamily domain 2a protein was identified recently as a lysophosphatidylcholine (LPC) symporter with high affinity for LPC species enriched with DHA (LPC-DHA). To test the hypothesis that reproductive state and choline intake influence plasma LPC-DHA, we performed a post hoc analysis of samples available through 10 weeks of a previously conducted feeding study, which provided two doses of choline (480 and 930 mg/d) to non-pregnant (n 21), third-trimester pregnant (n 26), and lactating (n 24) women; all participants consumed 200 mg of supplemental DHA and 22 % of their daily choline intake as 2H-labelled choline. The effects of reproductive state and choline intake on total LPC-DHA (expressed as a percentage of LPC) and plasma enrichments of labelled LPC and LPC-DHA were assessed using mixed and generalised linear models. Reproductive state interacted with time (P = 0·001) to influence total LPC-DHA, which significantly increased by week 10 in non-pregnant women, but not in pregnant or lactating women. Contrary to total LPC-DHA, patterns of labelled LPC-DHA enrichments were discordant between pregnant and lactating women (P < 0·05), suggestive of unique, reproductive state-specific mechanisms that result in reduced production and/or enhanced clearance of LPC-DHA during pregnancy and lactation. Regardless of the reproductive state, women consuming 930 v. 480 mg choline per d exhibited no change in total LPC-DHA but higher d3-LPC-DHA (P = 0·02), indicating that higher choline intakes favour the production of LPC-DHA from the phosphatidylethanolamine N-methyltransferase pathway of phosphatidylcholine biosynthesis. Our results warrant further investigation into the effect of reproductive state and dietary choline on LPC-DHA dynamics and its contribution to DHA status.


2019 ◽  
Vol 104 (6) ◽  
pp. e48.2-e48
Author(s):  
A Patel ◽  
M Mazer-Amirshahi ◽  
G Fusch ◽  
A Chan ◽  
J van den Anker ◽  
...  

BackgroundThe U.S. Food and Drug Administration implemented the new Pregnancy and Lactation Labeling Rule (PLLR) in June 2015. Under PLLR, all new drug applications were to present a narrative risk assessment (as opposed to letter category), while drug approvals after June 2001, were required to phase in by June 2020. The purpose of this study was to assess the quality of presented pregnancy and lactation data in the drug labeling and degree of adherence to the PLLR.Design/MethodsWe reviewed the labeling data of all new molecular entities (NMEs) approved from 1999–2017. The pregnancy and lactation information was classified as: 1. Harmful to use 2. Safe to use 3. Consideration of safety and efficacy. For drugs approvals after June 2001, presence of pregnancy letter category system was noted.ResultsOf the 456 NMEs, 131 (29%) were classified as harmful to use in pregnancy and 207 (45%) as harmful to use during lactation. This number did not follow any specific pattern over the course of 19 years. Less than 1% of drugs were deemed to be safe during pregnancy or lactation. Human data was the source of pregnancy or lactation information for only 2% of drugs. Up to 70% of drugs belonged to each implementation schedule has yet to meet the PLLR compliance requirement.Conclusion(s)Pregnant and lactating women are mostly advised against use of medications that might be needed for their health and health of their infants based on very limited data. Pharmaceutical companies lagged behind the required adherence rule for labeling updates on pregnancy and lactation information.Disclosure(s)Nothing to disclose


2014 ◽  
Vol 112 (1) ◽  
pp. 112-121 ◽  
Author(s):  
Erin D. Lewis ◽  
Fatheema B. Subhan ◽  
Rhonda C. Bell ◽  
Linda J. McCargar ◽  
Jonathan M. Curtis ◽  
...  

Despite recommendations for higher choline intakes during pregnancy and lactation, there is limited research regarding maternal intake during these important periods. In the present study, we estimated dietary choline intake during pregnancy and lactation in a population of Albertan women and the contribution of egg and milk consumption to intake. Dietary intake data were collected from the first 600 women enrolled in a prospective cohort study carried out in Alberta, Canada. During the first and/or second trimester, the third trimester and 3 months postpartum, 24 h dietary intake recall data were collected. A database was constructed including foods consumed by the cohort and used to estimate dietary choline intake. The mean total choline intake value during pregnancy was 347 (sd149) mg/d, with 23 % of the participants meeting the adequate intake (AI) recommendation. During lactation, the mean total choline intake value was 346 (sd151) mg/d, with 10 % of the participants meeting the AI recommendation. Phosphatidylcholine was the form of choline consumed in the highest proportion and the main dietary sources of choline were dairy products, eggs and meat. Women who consumed at least one egg in a 24 h period had higher (P< 0·001) total choline intake and were eight times more likely (95 % CI 5·2, 12·6) to meet choline intake recommendations compared with those who did not consume eggs during pregnancy. Women who reported consuming ≥ 500 ml of milk in a 24 h period were 2·8 times more likely (95 % CI 1·7, 4·8) to meet daily choline intake recommendations compared with those consuming < 250 ml of milk/d during pregnancy. Choline intake is below the recommendation levels in this population and the promotion of both egg and milk consumption may assist in meeting the daily choline intake recommendations.


2019 ◽  
Vol 78 ◽  
pp. 42-48 ◽  
Author(s):  
Sergio Dahdouh ◽  
Fernanda Grande ◽  
Sarah Nájera Espinosa ◽  
Anna Vincent ◽  
Rosalind Gibson ◽  
...  
Keyword(s):  

2021 ◽  
Vol 10 (11) ◽  
pp. 2314
Author(s):  
Mikolaj Przydacz ◽  
Marcin Chlosta ◽  
Piotr Chlosta

Objectives: Population-level data are lacking for urinary incontinence (UI) in Central and Eastern European countries. Therefore, the objective of this study was to estimate the prevalence, bother, and behavior regarding treatment for UI in a population-representative group of Polish adults aged ≥ 40 years. Methods: Data for this epidemiological study were derived from the larger LUTS POLAND project, in which a group of adults that typified the Polish population were surveyed, by telephone, about lower urinary tract symptoms. Respondents were classified by age, sex, and place of residence. UI was assessed with a standard protocol and established International Continence Society definitions. Results: The LUTS POLAND survey included 6005 completed interviews. The prevalence of UI was 14.6–25.4%; women reported a greater occurrence compared with men (p < 0.001). For both sexes, UI prevalence increased with age. Stress UI was the most common type of UI in women, and urgency UI was the most prevalent in men. We did not find a difference in prevalence between urban and rural areas. Individuals were greatly bothered by UI. For women, mixed UI was the most bothersome, whereas for men, leak for no reason was most annoying. More than half of respondents (51.4–62.3%) who reported UI expressed anxiety about the effect of UI on their quality of life. Nevertheless, only around one third (29.2–38.1%) of respondents with UI sought treatment, most of whom received treatment. Persons from urban and rural areas did not differ in the degrees of treatment seeking and treatment receiving. Conclusion: Urinary incontinence was prevalent and greatly bothersome among Polish adults aged ≥ 40 years. Consequently, UI had detrimental effects on quality of life. Nonetheless, most affected persons did not seek treatment. Therefore, we need to increase population awareness in Poland about UI and available treatment methods, and we need to ensure adequate allocation of government and healthcare system resources.


2015 ◽  
Vol 66 (12) ◽  
pp. 1278 ◽  
Author(s):  
Diriba B. Kumssa ◽  
Edward J. M. Joy ◽  
E. Louise Ander ◽  
Michael J. Watts ◽  
Scott D. Young ◽  
...  

Magnesium (Mg) is an essential mineral micronutrient in humans. Risks of dietary Mg deficiency are affected by the quantity of Mg ingested and its bioavailability, which is influenced by the consumption of other nutrients and ‘anti-nutrients’. Here, we assess global dietary Mg supplies and risks of dietary deficiency, including the influence of other nutrients. Food supply and food composition data were used to derive the amount of Mg available per capita at national levels. Supplies of Mg were compared with estimated national per capita average requirement ‘cut points’. In 2011, global weighted mean Mg supply was 613 ± 69 mg person–1 day–1 compared with a weighted estimated average requirement for Mg of 173 mg person–1 day–1. This indicates a low risk of dietary Mg deficiency of 0.26% based on supply. This contrasts with published data from national individual-level dietary surveys, which indicate greater Mg deficiency risks. However, individuals in high-income countries are likely to under-report food consumption, which could lead to overestimation of deficiency risks. Furthermore, estimates of deficiency risk based on supply do not account for potential inhibitors of Mg absorption, including calcium, phytic acid and oxalate, and do not consider household food wastage.


Author(s):  
Anna Ferrante ◽  
James Boyd ◽  
Sean Randall ◽  
Adrian Brown ◽  
James Semmens

ABSTRACT ObjectivesRecord linkage is a powerful technique which transforms discrete episode data into longitudinal person-based records. These records enable the construction and analysis of complex pathways of health and disease progression, and service use. Achieving high linkage quality is essential for ensuring the quality and integrity of research based on linked data. The methods used to assess linkage quality will depend on the volume and characteristics of the datasets involved, the processes used for linkage and the additional information available for quality assessment. This paper proposes and evaluates two methods to routinely assess linkage quality. ApproachLinkage units currently use a range of methods to measure, monitor and improve linkage quality; however, no common approach or standards exist. There is an urgent need to develop “best practices” in evaluating, reporting and benchmarking linkage quality. In assessing linkage quality, of primary interest is in knowing the number of true matches and non-matches identified as links and non-links. Any misclassification of matches within these groups introduces linkage errors. We present efforts to develop sharable methods to measure linkage quality in Australia. This includes a sampling-based method to estimate both precision (accuracy) and recall (sensitivity) following record linkage and a benchmarking method - a transparent and transportable methodology to benchmark the quality of linkages across different operational environments. ResultsThe sampling-based method achieved estimates of linkage quality that were very close to actual linkage quality metrics. This method presents as a feasible means of accurately estimating matching quality and refining linkages in population level linkage studies. The benchmarking method provides a systematic approach to estimating linkage quality with a set of open and shareable datasets and a set of well-defined, established performance metrics. The method provides an opportunity to benchmark the linkage quality of different record linkage operations. Both methods have the potential to assess the inter-rater reliability of clerical reviews. ConclusionsBoth methods produce reliable estimates of linkage quality enabling the exchange of information within and between linkage communities. It is important that researchers can assess risk in studies using record linkage techniques. Understanding the impact of linkage quality on research outputs highlights a need for standard methods to routinely measure linkage quality. These two methods provide a good start to the quality process, but it is important to identify standards and good practices in all parts of the linkage process (pre-processing, standardising activities, linkage, grouping and extracting).


Sign in / Sign up

Export Citation Format

Share Document